Undoctored vault view

A person in Tāmaki Makaurau has been confirmed with measles after recent overseas travel.

A public hearing on the Environmental Protection Authority’s (EPA) proposed updates to the Cosmetic Products Group Standard, which contains rules for cosmetics in Aotearoa New Zealand, will be held on Wednesday 20 September 2023

Te Whatu Ora is extremely disappointed the Association of Salaried Medical Specialists (ASMS) is indicating further industrial action by senior doctors and dentists, without letting their members know the details of the current pay offer.

A new cervical screening test, available from today, is expected to increase screening rates and significantly reduce cervical cancer deaths in Aotearoa New Zealand.

Auckland based Douglas Pharmaceuticals has signed a license agreement with U.S based Daré Bioscience, Inc to develop and commercialise R-131-2, a novel topical medicinal candidate for the treatment for cervical intraepithelial neoplasia.

Te Pātaka Whaioranga – Pharmac has confirmed supply agreements for a range of funded vaccines including those that protect against influenza and meningococcal disease. This follows a request for proposals (RFP) competitive process

Women who use non-steroidal anti-inflammatory painkillers alongside hormonal contraception appear to be at a small increased risk of blood clots known as venous thromboembolism (VTE), finds a large Danish study published by The BMJ

Emergency doctors are calling for appropriately trained security staff to be posted 24-hours a day in every emergency department (ED), and for other measures to protect and restore the nation’s struggling EDs and staff – and get more patients the healthcare they need

People with haemophilia A and multiple sclerosis are set to benefit from a multi-medicine funding agreement between Pharmac and Roche Products (NZ), confirmed today

A seven year battle on behalf of hundreds of people living with the most debilitating form of Multiple Sclerosis has been won – with Pharmac agreeing to fund Aotearoa New Zealand’s first ever treatment for the disease variant  from October 1st